PUTRAJAYA, April 4 (Bernama) — Malaysia has surpassed the RM1 billion mark in gross national income of clinical research contract value generated since 2012. The country also reported more than 2000 sponsored research approved by the various ethics committes in the last decade, and thus ranks third among Southeast Asia countries in this field.
This was revealed during the CRM launching ceremony of its 2022 Annual Report that was officiated by the Minister of Health, YB Dr. Zaliha Mustafa. At the same time, the Minister also launched the Organization’s Anti-Corruption Plan (OACP 2023 – 2027). With the OACP in place, CRM emphasises its commitment in demonstrating integrity and holding on to its highest standards of ethics in its operations through its anti-bribery management system.